[{"address1": "200 Pine Street", "address2": "Suite 400", "city": "San Francisco", "state": "CA", "zip": "94104", "country": "United States", "phone": "415 371 8300", "website": "https://jaguar.health", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. The company operates through two segments, Animal Health and Human Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. The company offers Mytesi, an anti-secretory antidiarrheal drug for the symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy; and Canalevia-CA1, a prescription drug product for chemotherapy-induced diarrhea in dogs. It is also developing Crofelemer, an anti-secretory antidiarrheal drug, which is in Phase III clinical trial for prophylaxis of diarrhea in adult cancer patients; Phase II clinical trials for rare/orphan disease indications, including short bowel syndrome with intestinal failure and microvillus inclusion disease; diarrhea-predominant irritable bowel syndrome; and for idiopathic/functional diarrhea. In addition, the company is developing Mytesi which is in Phase III clinical trial for cancer therapy-related diarrhea, as well as Phase II clinical trial for irritable bowel syndrome; and NP-300, a second-generation antidiarrheal drug that is in Phase I clinical trial for symptomatic relief and treatment of moderate-to-severe diarrhea. The company is headquartered in San Francisco, California.", "fullTimeEmployees": 49, "companyOfficers": [{"maxAge": 1, "name": "Ms. Lisa A. Conte", "age": 65, "title": "Founder, CEO, President & Director", "yearBorn": 1959, "fiscalYear": 2024, "totalPay": 693865, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Pravin R. Chaturvedi Ph.D.", "age": 61, "title": "Chief Scientific Officer & Chair of Scientific Advisory Board", "yearBorn": 1963, "fiscalYear": 2024, "totalPay": 592507, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jonathan S. Wolin CPA, J.D., M.B.A.", "age": 62, "title": "Chief of Staff, Chief Compliance Officer & General Counsel", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 520087, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven R. King Ph.D.", "age": 66, "title": "Chief of Sustainable Supply, Ethnobotanical Research & Intellectual Property and Secretary", "yearBorn": 1958, "fiscalYear": 2024, "totalPay": 461782, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carol R. Lizak M.B.A.", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Peter  Hodge", "title": "Senior Director of Investor Relations, Business Development & Special Events", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Karen J. Brunke Ph.D.", "age": 72, "title": "Executive VP of Corporate & Business Development", "yearBorn": 1952, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Sesin Ph.D.", "title": "Chief Manufacturing Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ian H. Wendt M.B.A.", "age": 56, "title": "Chief Commercial Officer", "yearBorn": 1968, "fiscalYear": 2024, "totalPay": 441310, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Massimo  Radaelli M.B.A., Ph.D.", "age": 66, "title": "President of Jaguar International", "yearBorn": 1958, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.3, "open": 2.2, "dayLow": 1.94, "dayHigh": 2.275, "regularMarketPreviousClose": 2.3, "regularMarketOpen": 2.2, "regularMarketDayLow": 1.94, "regularMarketDayHigh": 2.275, "payoutRatio": 0.0, "beta": 0.608, "trailingPE": 0.055155877, "forwardPE": -0.79310346, "volume": 383903, "regularMarketVolume": 383903, "averageVolume": 152826, "averageVolume10days": 234900, "averageDailyVolume10Day": 234900, "bid": 2.0, "ask": 2.17, "bidSize": 1, "askSize": 1, "marketCap": 7673740, "fiftyTwoWeekLow": 1.57, "fiftyTwoWeekHigh": 33.25, "allTimeHigh": 2501887490.0, "allTimeLow": 1.57, "priceToSalesTrailing12Months": 0.6497663, "fiftyDayAverage": 2.0153, "twoHundredDayAverage": 8.641505, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 34201920, "profitMargins": 0.0, "floatShares": 1522824, "sharesOutstanding": 3707121, "sharesShort": 77686, "sharesShortPriorMonth": 66131, "sharesShortPreviousMonthDate": 1756425600, "dateShortInterest": 1759190400, "sharesPercentSharesOut": 0.022, "heldPercentInsiders": 0.20007999, "heldPercentInstitutions": 0.0038800002, "shortRatio": 0.45, "shortPercentOfFloat": 0.022, "impliedSharesOutstanding": 3707121, "bookValue": 3.596, "priceToBook": 0.5756396, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -40645000, "trailingEps": 37.53, "forwardEps": -2.61, "lastSplitFactor": "1:25", "lastSplitDate": 1742774400, "enterpriseToRevenue": 2.896, "enterpriseToEbitda": -1.105, "52WeekChange": -0.9342857, "SandP52WeekChange": 0.118204355, "quoteType": "EQUITY", "currentPrice": 2.07, "targetHighPrice": 35.0, "targetLowPrice": 16.0, "targetMeanPrice": 25.5, "targetMedianPrice": 25.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 2207000, "totalCashPerShare": 1.015, "ebitda": -30938000, "totalDebt": 30530000, "quickRatio": 0.121, "currentRatio": 0.955, "totalRevenue": 11810000, "debtToEquity": 443.75, "revenuePerShare": 7.718, "returnOnAssets": -0.37418997, "returnOnEquity": -3.19246, "grossProfits": 9670000, "freeCashflow": -16042375, "operatingCashflow": -27676000, "revenueGrowth": 0.095, "grossMargins": 0.8188, "ebitdaMargins": -2.6196399, "operatingMargins": -2.68781, "financialCurrency": "USD", "symbol": "JAGX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "postMarketTime": 1760138902, "regularMarketTime": 1760126402, "earningsTimestamp": 1755174600, "earningsTimestampStart": 1763037000, "earningsTimestampEnd": 1763037000, "earningsCallTimestampStart": 1755174600, "earningsCallTimestampEnd": 1755174600, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": 37.53, "epsForward": -2.61, "epsCurrentYear": -23.81, "priceEpsCurrentYear": -0.08693826, "fiftyDayAverageChange": 0.054699898, "fiftyDayAverageChangePercent": 0.02714231, "twoHundredDayAverageChange": -6.5715055, "twoHundredDayAverageChangePercent": -0.7604584, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "longName": "Jaguar Health, Inc.", "shortName": "Jaguar Health, Inc.", "exchange": "NCM", "messageBoardId": "finmb_12827020", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -10.0, "regularMarketPrice": 2.07, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1431437400000, "postMarketChangePercent": 0.289857, "postMarketPrice": 2.076, "postMarketChange": 0.00600004, "regularMarketChange": -0.23, "regularMarketDayRange": "1.94 - 2.275", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 152826, "fiftyTwoWeekLowChange": 0.49999988, "fiftyTwoWeekLowChangePercent": 0.31847125, "fiftyTwoWeekRange": "1.57 - 33.25", "fiftyTwoWeekHighChange": -31.18, "fiftyTwoWeekHighChangePercent": -0.9377444, "fiftyTwoWeekChangePercent": -93.42857, "dividendDate": 1559865600, "displayName": "Jaguar Health", "trailingPegRatio": null, "__fetch_time": "2025-10-11"}]